Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease

NCT06449339 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

474

Enrollment

OTHER

Sponsor class

Conditions

Portal Hypertension
Hepatic Decompensation
Advanced Chronic Liver Disease

Interventions

DRUG: Carvedilol

Sponsor

Chinese University of Hong Kong

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]